Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world: The retrospective IMAGE study.
Olivier DecauxJean FontanAurore PerrotLionel KarlinCyrille TouzeauSamantha SchulmannSalomon ManierKarim BelhadjAdrien TrebouetPatricia ZunicJean-Marc Schiano De ColellaBrice CastelZoé Van De WyngaertGian Matteo PicaMourad TiabFrédérique KuhnowskiMalek BouketoucheSophia RigaudeauRiad BenramdaneChristina TekleRadhia LaforeMarianne GaucherJill CorreXavier LeleuPublished in: European journal of haematology (2024)
IMAGE demonstrated Isa-Pd had meaningful effectiveness in median PFS and depth of response and no new safety signals in a real-world context, consistent with clinical trial results.